
    
      This study is strategically positioned in the medical treatment safety and efficacy context,
      that is Lanreotide can be safely and effectively used in combination with other agents, like
      Metformin.

      Aim of this study is to verify the safety of a concomitant administration of Lanreotide 120
      mg ATG with Metformin in advanced, progressing gastro-intestinal or lung carcinoids patients,
      by accurately monitor patients from a tolerability point of view during all study long.
    
  